Christopher’s role primarily focuses on leading the development of value stories, value dossiers, HTA submissions, and payer objection handlers. He has particular experience in oncology (including cell transfer technologies and immunotherapies) and orphan diseases, as well as in developing web-based interactive communication tools for a variety of clients.
Prior to joining Evidera, Christopher gained experience producing other types of market access deliverables, including interactive multimedia toolkits, user-friendly Excel models, and detail aids.
Christopher holds an MRes and a PhD in neuroscience from Imperial College London. His doctoral thesis focused on the development of a novel model of multiple sclerosis. His work has been peer-reviewed and published in scientific journals, and presented at international conferences.